| - GRCh37:
- Chr6:30884970
- GRCh38:
- Chr6:30917193
| VARS2 | C141Y, C281Y, C311Y | Combined oxidative phosphorylation defect type 20 | Uncertain significance (May 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30883557
- GRCh38:
- Chr6:30915780
| VARS2 | M141fs, M171fs | Combined oxidative phosphorylation defect type 20 | Pathogenic (Aug 9, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30888840
- GRCh38:
- Chr6:30921063
| VARS2 | | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Jul 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30893977
- GRCh38:
- Chr6:30926200
| VARS2 | P1061L, P1091L, P921L | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Nov 6, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30888162
- GRCh38:
- Chr6:30920385
| VARS2 | W309*, W449*, W479* | Combined oxidative phosphorylation defect type 20 | Conflicting interpretations of pathogenicity (Aug 24, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30890952
- GRCh38:
- Chr6:30923175
| LOC126859646, VARS2 | L613F, L753F, L783F | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Jan 6, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30886684
- GRCh38:
- Chr6:30918907
| VARS2 | R216*, R356*, R386* | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30883640
- GRCh38:
- Chr6:30915863
| VARS2 | R168C, R198C, R28C | not provided, Combined oxidative phosphorylation defect type 20 | Uncertain significance (Dec 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30889033
- GRCh38:
- Chr6:30921256
| VARS2 | W388*, W528*, W558* | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Oct 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30883641
- GRCh38:
- Chr6:30915864
| VARS2 | R168H, R198H, R28H | Combined oxidative phosphorylation defect type 20, not provided | Uncertain significance (May 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30889075
- GRCh38:
- Chr6:30921298
| VARS2 | H402R, H542R, H572R | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Jun 12, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30893069
- GRCh38:
- Chr6:30925292
| VARS2 | E758*, E898*, E928* | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30887851
- GRCh38:
- Chr6:30920074
| VARS2 | | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30882594-30882600
- GRCh38:
- Chr6:30914817-30914823
| VARS2 | P25fs | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Feb 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30892253
- GRCh38:
- Chr6:30924476
| VARS2 | E723D, E863D, E893D | not provided, Combined oxidative phosphorylation defect type 20 | Conflicting interpretations of pathogenicity (May 12, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30884719
- GRCh38:
- Chr6:30916942
| VARS2 | C106R, C246R, C276R | Combined oxidative phosphorylation defect type 20, not provided | Conflicting interpretations of pathogenicity (Apr 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30893887
- GRCh38:
- Chr6:30926110
| VARS2 | L891R, L1031R, L1061R | Inborn genetic diseases, not provided, Combined oxidative phosphorylation defect type 20
| Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30893061
- GRCh38:
- Chr6:30925284
| VARS2 | R755H, R925H, R895H | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Jan 22, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30892288
- GRCh38:
- Chr6:30924511
| VARS2 | P875L, P905L, P735L | Inborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided
| Uncertain significance (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30882755
- GRCh38:
- Chr6:30914978
| VARS2 | Q48E, Q78E | Inborn genetic diseases, Combined oxidative phosphorylation defect type 20 | Uncertain significance (Jun 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30890482
- GRCh38:
- Chr6:30922705
| LOC126859646, VARS2 | | Combined oxidative phosphorylation defect type 20 | Pathogenic (Feb 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30890248
- GRCh38:
- Chr6:30922471
| LOC126859646, VARS2 | R512W, R652W, R682W | Inborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided, See cases | Uncertain significance (Aug 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30883986
- GRCh38:
- Chr6:30916209
| VARS2 | R71W, R241W, R211W | Combined oxidative phosphorylation defect type 20, not provided | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30883006
- GRCh38:
- Chr6:30915229
| VARS2 | E122G, E92G | Combined oxidative phosphorylation defect type 20, not provided | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30893700
- GRCh38:
- Chr6:30925923
| VARS2 | R862Q, R1032Q, R1002Q | Combined oxidative phosphorylation defect type 20, not provided | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30893396-30893397
- GRCh38:
- Chr6:30925619-30925620
| VARS2 | L821fs, L991fs, L961fs | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Nov 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30892165
- GRCh38:
- Chr6:30924388
| VARS2 | R834H, R694H, R864H | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Mar 8, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30893135
- GRCh38:
- Chr6:30925358
| VARS2 | Y780H, Y920H, Y950H | Combined oxidative phosphorylation defect type 20 | Pathogenic (Feb 22, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr6:30892129
- GRCh38:
- Chr6:30924352
| VARS2 | | Combined oxidative phosphorylation defect type 20, not provided | Pathogenic/Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30886678
- GRCh38:
- Chr6:30918901
| VARS2 | D384N, D214N, D354N | Combined oxidative phosphorylation defect type 20 | Pathogenic (Jul 9, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr6:30890717
- GRCh38:
- Chr6:30922940
| LOC126859646, VARS2 | A747T, A577T, A717T | Combined oxidative phosphorylation defect type 20 | Pathogenic (Jul 9, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr6:30888447
- GRCh38:
- Chr6:30920670
| VARS2 | R497H, R327H, R467H | Combined oxidative phosphorylation defect type 20 | Uncertain significance (Dec 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30888503
- GRCh38:
- Chr6:30920726
| VARS2 | E516*, E346*, E486* | Combined oxidative phosphorylation defect type 20, not provided, Inborn genetic diseases
| Pathogenic/Likely pathogenic (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30889370
- GRCh38:
- Chr6:30921593
| VARS2 | E406V, E546V, E576V | Combined oxidative phosphorylation defect type 20 | Uncertain significance (May 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30889424
- GRCh38:
- Chr6:30921647
| VARS2 | A424V, A564V, A594V | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Conflicting interpretations of pathogenicity (Aug 10, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30889920-30889921
- GRCh38:
- Chr6:30922143-30922144
| LOC126859646, VARS2 | L472fs, L612fs, L642fs | Combined oxidative phosphorylation defect type 20 | Pathogenic/Likely pathogenic (Mar 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30883879-30883886
- GRCh38:
- Chr6:30916102-30916109
| VARS2 | | not provided, Combined oxidative phosphorylation defect type 20 | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30882717
- GRCh38:
- Chr6:30914940
| VARS2 | H35R, H65R | Inborn genetic diseases, Combined oxidative phosphorylation defect type 20 | Uncertain significance (Mar 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30893715
- GRCh38:
- Chr6:30925938
| VARS2 | Q1007R, Q1037R, Q867R | Combined oxidative phosphorylation defect type 20, not provided | Uncertain significance (May 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30886590
- GRCh38:
- Chr6:30918813
| VARS2 | | Combined oxidative phosphorylation defect type 20 | Uncertain significance (May 4, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30887868
- GRCh38:
- Chr6:30920091
| VARS2 | A390T, A420T, A250T | VARS2-related condition, Inborn genetic diseases, not provided, See cases, Combined oxidative phosphorylation defect type 20 | Conflicting interpretations of pathogenicity (Nov 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30888508-30888510
- GRCh38:
- Chr6:30920731-30920733
| VARS2 | G488del, G348del, G518del | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Nov 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30888447
- GRCh38:
- Chr6:30920670
| VARS2 | R467P, R327P, R497P | Combined oxidative phosphorylation defect type 20 | Likely pathogenic (Nov 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30883762
- GRCh38:
- Chr6:30915985
| VARS2 | R171W, R201W, R31W | Inborn genetic diseases, not provided, Combined oxidative phosphorylation defect type 20
| Conflicting interpretations of pathogenicity (Jan 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30892215
- GRCh38:
- Chr6:30924438
| VARS2 | R851C, R881C, R711C | Combined oxidative phosphorylation defect type 20, not provided | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:30893728
- GRCh38:
- Chr6:30925951
| VARS2 | | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30893127
- GRCh38:
- Chr6:30925350
| VARS2 | R917Q, R947Q, R777Q | Combined oxidative phosphorylation defect type 20, not specified, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30890871
- GRCh38:
- Chr6:30923094
| LOC126859646, VARS2 | | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30890483
- GRCh38:
- Chr6:30922706
| LOC126859646, VARS2 | V680L, V710L, V540L | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30888161
- GRCh38:
- Chr6:30920384
| VARS2 | W449R, W479R, W309R | not provided, not specified, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30887972
- GRCh38:
- Chr6:30920195
| VARS2 | | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30882203
- GRCh38:
- Chr6:30914426
| VARS2 | | not specified, not provided, Combined oxidative phosphorylation defect type 20
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30889936
- GRCh38:
- Chr6:30922159
| LOC126859646, VARS2 | T617M, T647M, T477M | not specified | Uncertain significance (Dec 15, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr6:30886628
- GRCh38:
- Chr6:30918851
| VARS2 | T367I, T337I, T197I | Inborn genetic diseases, Combined oxidative phosphorylation defect type 20, not provided
| Pathogenic (Jun 26, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:30889753
- GRCh38:
- Chr6:30921976
| LOC126859646, VARS2 | A626D, A596D, A456D | Combined oxidative phosphorylation defect type 20 | Pathogenic (Jul 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr6:30886663
- GRCh38:
- Chr6:30918886
| VARS2 | A379T, A349T, A209T | Combined oxidative phosphorylation defect type 20 | Pathogenic (Jul 2, 2014) | no assertion criteria provided |